1. Oral Solid Tablet
  2. Recombinant Protein

Zelgen has built up its commercial GMP manufacturing facilities for oral solid tablet preparations (11,000 square meters) and recombinant biologics (4,000 square meters), with ancillary facilities of power supply and sewage treatment systems. Zelgen has obtained Drug Manufacturing License. These facilities in compliance with cGMP guidelines provide Zelgen with flexible manufacturing capacity, cost effectiveness and competitive advantages.